There are the workhorses and the newcomers in the world of molecular imaging and biomarkers. What technologies and biomarkers are getting close to entering regular clinical practice? Which ones have a ways to go? Four experts offer thier opinions and rationale.

For more than 50 years, speculation has swirled about the tremendous potential of Ga-68 PET imaging to transform molecular imaging. The rapidly increasing number of publications reporting the results of Ga-68 PET imaging studies are evidence that many are working in this direction. 

In the latest “Medical Edge Newspaper Column” from the Mayo Clinic, Stephanie Hines, MD, of Mayo’s Breast Clinic in Jacksonville, Fla., responds to a question about why mammography is the recommended first test in breast cancer screening over MRI. The article offers a quick refresher on the basics of how the two modalities are used to screen for breast cancer.

Delayed brain injury resulting from aggressive radiation treatment can be differentiated from recurrent brain tumors using F-18 FDOPA PET imaging, according to a study published Oct. 28 in the Journal of Nuclear Medicine.

Silvergate Pharmaceuticals, Inc., focused on the development and commercialization of innovative and safe medicines for children, today announced the availability by prescription of Epaned(tm) (enalapril maleate Powder for Oral Solution) to treat hypertension (high blood pressure) in people older than one month. Enalapril is one of the most commonly prescribed medicines in the United States to treat high blood pressure.

Baseline measures of salience network connectivity involving the left insula may predict behavioral changes in patients with frontotemporal dementia, according to a study published in the October issue of JAMA Neurology.

New research brings 11 new genes into focus as potential links to Alzheimer's and other neurodegenerative diseases including Parkinson's and multiple sclerosis, all associated with the build-up of protein plaques in the brain. The data was made available as a result of the international Genomics of Alzheimer's Project (IGAP), according to an Oct. 28 report by The Huffington Post.

The global PET market is set to grow an estimated 3.74 percent from 2012-2016, according to a report published this month by the market research firm Infiniti Research Limited.